DNA damage in lymphocytes from COPD patients with and without lung cancer

R. Ferrari (Botucatu/Sp, Brazil)

Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Session: Latest insights into the management of chronic lung diseases
Session type: Thematic Poster
Number: 3680
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Ferrari (Botucatu/Sp, Brazil). DNA damage in lymphocytes from COPD patients with and without lung cancer. 3680

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Pecularities of lung cancer in patients with COPD
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011


The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006

How to treat lung cancer in IPF patients
Source: Research Seminar 2015
Year: 2015

COPD in patients with lung cancer and smoking
Source: Eur Respir J 2005; 26: Suppl. 49, 519s
Year: 2005

Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005

COPD, asthma, and lung cancer patients
Source: International Congress 2016 – ME13 Smoking cessation in difficult population groups
Year: 2016



Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Coexistence of COPD in lung cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001

A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018



Intersections of lung progenitor cells, lung disease and lung cancer
Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017
Year: 2017



The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Subsequent COPD and lung cancer in patients with autoimmune disease
Source: Eur Respir J 2011; 37: 463
Year: 2011


Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Apoptosis of circulating and BALF lymphocytes of patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 44s
Year: 2004

DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013


Management of concomitant COPD in patients with lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018

Angiogenetic and apoptotic process in the airways of symptomatic smokers with and without a contralateral non small cell lung cancer
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009


Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

COPD and lung cancer incidence in never smokers
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019